Use of Epinephrine Nasal Spray.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 16 Sponsors

No sponsors recorded.

PASSAGE PROBABILITY

35.4% Uncertain

Why this number

Stage base Passed First Chamber — base rate 52%, measured from NC's completed sessions
Momentum +6 76/100 from the pace of recorded action
Time since last action -22 577 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.